We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
2276
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $296K | ﹤0.01% |
49,713
+13,308
| +37% | +$88.6K |
|
|
ADAM
2277
Adamas Trust
ADAM
$880M
| $295K | ﹤0.01% |
22,896
+9,185
| +67% | +$134K |
|
|
FLNA
2278
Filana Therapeutics
FLNA
$48.2M
| $295K | ﹤0.01% |
14,128
+1,938
| +16% | +$82.1K |
|
|
SCPL
2279
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $294K | ﹤0.01% |
22,042
+7,401
| +51% | +$93.5K |
|
2280
Seneca Foods Class A
SENEA
$1.22B
| $293K | ﹤0.01% |
5,678
+54
| +1% | +$2.65K |
|
2281
Stoke Therapeutics
STOK
$2.08B
| $292K | ﹤0.01% |
20,224
-45,947
| -69% | -$920K |
|
|
DSKE
2282
DELISTED
Daseke, Inc. Common Stock
DSKE
| $291K | ﹤0.01% |
+34,701
| New | +$377K |
|
2283
Children's Place
PLCE
$58.3M
| $290K | ﹤0.01% |
6,263
+2,517
| +67% | +$160K |
|
2284
Beyond Meat
BYND
$268M
| $288K | ﹤0.01% |
7,803
+339
| +5% | +$18.6K |
|
2285
Advantage Solutions
ADV
$383M
| $287K | ﹤0.01% |
+2,283
| New | +$395K |
|
|
SNBR
2286
DELISTED
Sleep Number
SNBR
| $287K | ﹤0.01% |
7,086
+3,088
| +77% | +$210K |
|
2287
Atlanticus Holdings
ATLC
$1.45B
| $286K | ﹤0.01% |
6,641
+909
| +16% | +$54.6K |
|
2288
Utz Brands
UTZ
$1.25B
| $286K | ﹤0.01% |
+20,286
| New | +$317K |
|
2289
Anika Therapeutics
ANIK
$277M
| $285K | ﹤0.01% |
13,244
+3,805
| +40% | +$116K |
|
2290
Hercules Capital
HTGC
$3.21B
| $285K | ﹤0.01% |
16,940
+80
| +0.5% | +$1.41K |
|
2291
PTC Therapeutics
PTCT
$6.23B
| $285K | ﹤0.01% |
8,076
-152
| -2% | -$5.86K |
|
|
NEX
2292
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $285K | ﹤0.01% |
25,860
-540
| -2% | -$3.87K |
|
|
OLPX
2293
DELISTED
Olaplex Holdings
OLPX
| $283K | ﹤0.01% |
19,250
+8,879
| +86% | +$169K |
|
2294
Hayward Holdings
HAYW
$3.27B
| $282K | ﹤0.01% |
17,725
-506
| -3% | -$9.57K |
|
|
RETA
2295
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $281K | ﹤0.01% |
11,053
-73
| -0.7% | -$2.17K |
|
2296
Bioventus
BVS
$1.17B
| $279K | ﹤0.01% |
+23,208
| New | +$311K |
|
2297
Fulcrum Therapeutics
FULC
$286M
| $278K | ﹤0.01% |
+28,907
| New | +$409K |
|
2298
SES AI
SES
$196M
| $276K | ﹤0.01% |
+42,803
| New | +$323K |
|
2299
Revolve Group
RVLV
$1.73B
| $275K | ﹤0.01% |
6,498
-3,578
| -36% | -$182K |
|
|
RNAM
2300
DELISTED
Avidity Biosciences
RNAM
| $273K | ﹤0.01% |
19,093
-267
| -1% | -$4.54K |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.